Second-line endovascular treatment for acute DVT
Part of Heart & circulation clinical trials.
This trial tests a second-line endovascular procedure (a catheter-based treatment inside the vein) for people with acute deep vein thrombosis (a blood clot in the deep veins of the leg). It may help if the first blood thinner treatment isn't enough or can't be used.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 75 years old
- A blood clot in the deep veins of the thigh or behind the knee
- Symptoms started less than 14 days ago
- No conditions that make blood thinners unsafe (like high bleeding risk)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This trial studies a procedure to remove an acute deep vein blood clot in the leg. It may help restore blood flow faster than standard treatment for certain clot locations.
This trial compares different mechanical devices used to remove recent blood clots from the deep veins in your leg (iliac and femoral veins). The goal is to restore blood flow and prevent long-term complications like chronic pain and swelling.
This study tests a treatment approach for acute blood clots in the deep veins of the upper leg and groin. It aims to see if using a device to clear the clot after standard treatment improves recovery.
This study tests a device that removes blood clots from the deep veins of your leg. It's designed to help people with recent or slightly older clots in the thigh or pelvic area, aiming to reduce symptoms and prevent complications.
This trial tests a mechanical device that removes blood clots from deep veins in the pelvis or leg. It may be an option if you have a large clot and are at low risk for bleeding.
Hear when a new Deep Venous Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.